Wockhardt (NSE:WOCKPHARMA) ROCE % : 4.92% (As of Sep. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Wockhardt ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Wockhardt's annualized ROCE % for the quarter that ended in Sep. 2024 was 4.92%.

Wockhardt ROCE % Historical Data

The historical data trend for Wockhardt's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wockhardt ROCE % Chart

Wockhardt Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROCE %

Get a 7-Day Free Trial

-1.50

-6.96

-2.66

-7.15

-2.83

Wockhardt Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															3.46	-0.84	-9.96	5.52	4.92

Wockhardt ROCE % Calculation

Wockhardt's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	-1290	/	( ( (76830 - 34350)	+	(76490 - 27910) )	/ 2 )
	=	-1290	/	( (42480	+	48580)	/ 2 )
	=	-1290	/	45530
	=	-2.83 %

Wockhardt's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	2560	/	( ( (0 - 0)	+	(75880 - 23800) )	/ 1 )
	=	2560	/	( ( 0	+	52080 )	/ 1 )
	=	2560	/	52080
	=	4.92 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Wockhardt (NSE:WOCKPHARMA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Wockhardt ROCE % Related Terms

Thank you for viewing the detailed overview of Wockhardt's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Wockhardt Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wockhardt Ltd (NSE:WOCKPHARMA) » Definitions » ROCE %

Traded in Other Exchanges

532300:India

Address

Wockhardt Towers, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051

Website

https://www.wockhardt.com

Wockhardt Ltd is a drug manufacturing company focusing on pharmaceutical and biotechnology products. The company conducts research in the fields of pharmaceuticals and biotechnology while also operating its chain of Super Specialty Hospitals. The vast majority of the company's revenue is generated in Europe. The company also operates in the USA, Japan, Russia, and Rest of the world.

Wockhardt Headlines

No Headlines